Healthcare

10 Jan 2018  |  Asia Pacific

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Ko...

The South Korean endoscopy devices market is growing under relatively lower reimbursement rates and budget constraints that are forcing hospitals to provide greater importance to pricing of equipment and changing utilization patterns. In many South Korean hospitals, consolidated purchasing of endoscopy and laparoscopy equipment slows down procureme...

Nigeria has the largest consumer base in Sub-Saharan region. A larger part of the population living in urban areas is a favorable indicator for market entry. Robust growth of around 7% for the past decade is threatened by macroeconomic challenges, particularly exchange-rate volatility and falling global oil prices that impact public-sector spending...

Frost & Sullivan defines digital health to include telehealth and healthcare IT. Telehealth covers video telemedicine, remote patient monitoring (RPM), and mobile health (mHealth) and healthcare IT (in the APAC context) refers to the software solutions deployed across hospitals in the region. It is difficult to generalize or summarize the digital h...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the African healthcare industry in 2017. The markets covered include pharmaceuticals and biotechnology, in-vitro diagnostics, medical devices, medical imaging and healthcare IT. The analysis captures the impact of trends that are expected ...

This market insight aims to profile select medical device companies in Asia-Pacific for 2016. Research Scope: • The aim of this insight is to analyze and profile APAC medical device manufacturers, based on certain parameters. • It covers wound management, cardiovascular, orthopedic implants, infection control, and infusion...

Retail technology investment in Australia is projected to record a CAGR of 28.8% from 2016-2021 largely driven by evolving consumer requirements and intensifying retail competition from international entrants and new business models. These factors are set to raise standards across both the front and back ends of retail technology. Current investmen...

27 Sep 2017  |  Africa

East African Pharmaceutical Market, Forecast to 2021

Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers

Infographics

×

Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...

08 Aug 2017  |  Asia Pacific

Growth Opportunities in Asia-Pacific Hospital Healthcare Information Technology, 2016–2021

Hospitals Investing in Health Data Continuity, Big Data, Cloud, and Data Security to Improve Patient Experience

Infographics

×

Hospital health information technology (hospital IT) includes solutions that have a common end goal – to improve the quality of in-patient care while reducing cost. For the purpose of this report, the hospital IT market consists of software, solutions, and maintenance services but does not include hardware. The market is segmented into clinical i...